Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Organizations must base their cybersecurity strategies on resilience — the ability to weather an attack with minimal damage to data, finances, and reputation.
By
Cloud misconfigurations, more sophisticated ransomware, and exploitation of vendors are contributing to rising cyberattacks.
The Climate Policy Center will connect current and future climate research to policy, measuring the impact and implications of a variety of technologies on the climate system as a whole.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
The LFE is actively involved in research that aims to identify methods for measuring and managing risk, both standard and systemic types of risk.